Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Todd Lowther

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Antioxidants (Basel, Switzerland)|July 2, 2021
Specificity of Human Sulfiredoxin for Reductant and Peroxiredoxin Oligomeric StateTom E Forshaw, Julie A Reisz, Kimberly J Nelson, et al.
The Journal of Biological Chemistry|June 10, 2018
Novel hyperoxidation resistance motifs in 2-Cys peroxiredoxinsJesalyn A Bolduc, Kimberly J Nelson, Alexina C Haynes, et al.
Chemical Research in Toxicology|February 1, 2019
Aromatic Residues at the Dimer-Dimer Interface in the Peroxiredoxin Tsa1 Facilitate Decamer Formation and Biological FunctionMatthew A Loberg, Jennifer E Hurtig, Aaron H Graff, et al.
ACS Chemical Biology|July 9, 2017
Discovery of Heteroaromatic Sulfones As a New Class of Biologically Compatible Thiol-Selective ReagentsXiaofei Chen, Hanzhi Wu, Chung-Min Park, et al.
Molecular Pharmacology|November 30, 2016
Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding SitesLawrence C Blume, Theresa Patten, Khalil Eldeeb, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 14, 2020
End Points for Clinical Trials in Primary HyperoxaluriaDawn S Milliner, Tracy L McGregor, Aliza Thompson, et al.
Kidney International Reports|November 13, 2024
Opportunities in Primary and Enteric Hyperoxaluria at the Cross-Roads Between the Clinic and LaboratoryBarbara Cellini, Michelle A Baum, Yaacov Frishberg, et al.
ACS Medicinal Chemistry Letters|July 16, 2021
Dual Glycolate Oxidase/Lactate Dehydrogenase A Inhibitors for Primary HyperoxaluriaJinyue Ding, Rajesh Gumpena, Marc-Olivier Boily, et al.
Plos One|May 27, 2015
Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant MesotheliomaBrian Cunniff, Kheng Newick, Kimberly J Nelson, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Antioxidants (Basel, Switzerland)|July 2, 2021
Specificity of Human Sulfiredoxin for Reductant and Peroxiredoxin Oligomeric StateTom E Forshaw, Julie A Reisz, Kimberly J Nelson, et al.
The Journal of Biological Chemistry|June 10, 2018
Novel hyperoxidation resistance motifs in 2-Cys peroxiredoxinsJesalyn A Bolduc, Kimberly J Nelson, Alexina C Haynes, et al.
Chemical Research in Toxicology|February 1, 2019
Aromatic Residues at the Dimer-Dimer Interface in the Peroxiredoxin Tsa1 Facilitate Decamer Formation and Biological FunctionMatthew A Loberg, Jennifer E Hurtig, Aaron H Graff, et al.
ACS Chemical Biology|July 9, 2017
Discovery of Heteroaromatic Sulfones As a New Class of Biologically Compatible Thiol-Selective ReagentsXiaofei Chen, Hanzhi Wu, Chung-Min Park, et al.
Molecular Pharmacology|November 30, 2016
Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding SitesLawrence C Blume, Theresa Patten, Khalil Eldeeb, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 14, 2020
End Points for Clinical Trials in Primary HyperoxaluriaDawn S Milliner, Tracy L McGregor, Aliza Thompson, et al.
Kidney International Reports|November 13, 2024
Opportunities in Primary and Enteric Hyperoxaluria at the Cross-Roads Between the Clinic and LaboratoryBarbara Cellini, Michelle A Baum, Yaacov Frishberg, et al.
ACS Medicinal Chemistry Letters|July 16, 2021
Dual Glycolate Oxidase/Lactate Dehydrogenase A Inhibitors for Primary HyperoxaluriaJinyue Ding, Rajesh Gumpena, Marc-Olivier Boily, et al.
Plos One|May 27, 2015
Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant MesotheliomaBrian Cunniff, Kheng Newick, Kimberly J Nelson, et al.
Pageof 5